Glucosamine supplements may speed memory loss from Alzheimer’s, new research shows
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.
Posts tagged as
Mild Cognitive Impairment
Study links joint pain supplement to accelerating dementia
An analysis by MBI researchers shows that glucosamine use is associated with a 25% increase in progression from mild cognitive impairment to dementia.
MBI Rising Stars: Priscilla Amofa-Ho
Priscilla Amofa-Ho is the latest investigator to be featured in the MBI Rising Stars video series.
Cognitive aging T32 receives grant renewal
The program trains doctoral students to explore treatments to prevent or slow cognitive aging, mild cognitive impairment and Alzheimer’s disease.
